Free Newsletter
Sanofi agrees to boost female reps' pay
Sanofi-Aventis and its female sales reps in the U.S. have come to a deal. The drugmaker has agreed to pay $15.4 million to settle a class-action discrimination suit that alleges Sanofi underpaid and underpromoted its female reps.
The settlement agreement also requires Sanofi to analyze its sales-rep compensation and, wherever disparities between men and women are found, to adjust pay accordingly. The company also has to be more equitable about promoting women; in the past, Sanofi had favored men over women for training courses that prepare employees for management, the suit claims. Finally, the company has to boost its female reps' base pay, to the tune of $2 million now and up to nearly $10 million over the next three years, Pharmalot reports.
In fact, it's this pay adjustment that's the real win for women at Sanofi, as BNet Pharma points out. "Any female sales force employee who receives an upward base pay adjustment will then receive future pay raises from a higher base-level salary," the settlement states, "thus potentially having a significant future impact on class members' total compensation."
- see the Pharmalot post
- read the piece at BNet Pharma
Related Articles:
Top 15 Women in Pharma
Hiring reps is a song of experience
Ex-Novartis sales rep wins maternity-leave case
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: